Animal Models for OCD Research

Brittany L Chamberlain1,2, Susanne E Ahmari3,4

  • 1Department of Psychiatry, Translational Neuroscience Program, University of Pittsburgh, Pittsburgh, PA, USA.

Insights

Animal models are crucial for understanding Obsessive-Compulsive Disorder (OCD) pathophysiology. Research highlights cortico-basal ganglia-thalamic circuits and glutamatergic synapses, paving the way for novel OCD treatments.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Obsessive-Compulsive Disorder (OCD) lacks identified molecular treatment targets, hindering therapeutic advancements.
  • Genome-wide association studies have yielded limited findings, necessitating alternative research approaches.
  • OCD symptoms can be deconstructed into distinct neural functions amenable to study in animal models.

Purpose of the Study:

  • To review current strategies employing animal models for identifying molecules, cell types, and circuits relevant to OCD pathophysiology.
  • To explore how findings from animal models can inform the development of new treatments for OCD and related disorders.

Main Methods:

  • Review of studies in rodents and non-human primates focusing on cortico-basal ganglia-thalamic circuits.
  • Analysis of human post-mortem brain tissue research on glutamatergic synapse abnormalities.
  • Examination of animal model systems, including transgenic models and circuit manipulations.

Main Results:

  • Cortico-basal ganglia-thalamic circuits are implicated in OCD pathophysiology.
  • Glutamatergic synapse abnormalities are suggested as a cellular substrate for OCD behaviors.
  • Neuromodulators like serotonin and dopamine play a potential role in OCD pathology and treatment.

Conclusions:

  • Animal models offer valuable insights into OCD pathophysiology by dissecting circuit abnormalities and genetic factors.
  • Investigating OCD-relevant neural constructs in animal models aids in identifying potential therapeutic targets.
  • Findings from animal research hold promise for developing innovative treatment strategies for OCD.